| 2023-08-03 | -18.6% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-04-25 | +18.1% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2021-04-29 | -10.5% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-01-27 | -8.4% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-10-27 | -8.3% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-08-01 | +8.1% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-04 | +7.9% | earnings | TIKR.com | ResMed Slipped 1% on Profit Beat: Is $400 the 2026 Recovery Target? - TIKR.com |
| 2024-10-24 | +7.7% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-08-01 | +7.3% | news | Seeking Alpha | ResMed declares $0.60 dividend |
| 2025-08-01 | +7.3% | earnings | Seeking Alpha | ResMed Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-08-01 | +7.3% | news | Seeking Alpha | ResMed outlines 61%–63% gross margin target for FY26 while ramping up share buybacks and dividend |
| 2025-08-01 | +7.3% | earnings | Seeking Alpha | ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript |
| 2025-08-01 | +7.3% | legal | SEC EDGAR | RMD 8-K: 5.02 (SEC Filing) |
| 2025-04-23 | +6.6% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-01-30 | -6.6% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2024-01-24 | +5.9% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-10 | -5.6% | news | MarketWatch | ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch |
| 2022-04-28 | -5.6% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-11 | -5.2% | news | MarketWatch | ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch |
| 2023-04-27 | +4.7% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-03-11 | -4.3% | news | The Globe and Mail | ResMed (RMD) Stock Trades Down, Here Is Why - The Globe and Mail |
| 2023-11-09 | -4.3% | legal | SEC EDGAR | RMD 8-K: 5.02 and (SEC Filing) |
| 2023-01-26 | -4.2% | legal | SEC EDGAR | RMD 8-K: 2.02, 5.02, 8.01 (SEC Filing) |
| 2025-08-27 | -4.0% | news | Seeking Alpha | ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows |
| 2025-08-27 | -4.0% | news | Seeking Alpha | ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows (RMD) - Seeking Alpha |
| 2022-08-12 | -3.7% | legal | SEC EDGAR | RMD 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-04-15 | -3.6% | analyst | MT Newswires | Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating |
| 2026-04-15 | -3.6% | earnings | MarketBeat | ResMed Inc. $RMD Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat |
| 2026-01-22 | -3.2% | earnings | Finviz | ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Finviz |
| 2026-02-09 | -3.2% | news | Yahoo Finance | With 73% ownership in ResMed Inc. (NYSE:RMD), institutional investors have a lot riding on the business - Yahoo Finance |
| 2022-08-11 | -3.2% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2021-10-28 | -3.1% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-11-20 | +2.9% | legal | SEC EDGAR | RMD 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-10-02 | +2.7% | news | Yahoo Finance | Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Yahoo Finance |
| 2025-10-02 | +2.7% | executive | Quiver Quantitative | RESMED INC ($RMD) CEO 2025 Pay Revealed - Quiver Quantitative |
| 2026-04-14 | -2.7% | news | ChartMill | ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income - ChartMill |
| 2026-04-14 | -2.7% | earnings | MarketBeat | ResMed Inc. $RMD Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat |
| 2025-07-31 | +2.6% | earnings | Seeking Alpha | ResMed Non-GAAP EPS of $2.55 beats by $0.07, revenue of $1.3B misses by $30M |
| 2025-07-31 | +2.6% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-23 | -2.6% | news | ChartMill | ResMed Inc. (NYSE:RMD) Emerges as a Prime Quality Investing Candidate - ChartMill |
| 2026-01-14 | +2.6% | earnings | Yahoo Finance | Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD) - Yahoo Finance |
| 2026-01-14 | +2.6% | earnings | TradingView | ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings? - TradingView |
| 2025-10-27 | -2.6% | news | TradingView | Do Options Traders Know Something About ResMed Stock We Don't? - TradingView |
| 2023-10-26 | -2.5% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-02-26 | +2.5% | news | ChartMill | ResMed Inc (NYSE:RMD): A Durable Dividend Stock Built on Financial Strength - ChartMill |
| 2025-11-17 | +2.5% | news | Seeking Alpha | ResMed: Safe Bet For A Recession Environment |
| 2025-11-17 | +2.5% | news | Seeking Alpha | ResMed: Safe Bet For A Recession Environment (NYSE:RMD) - Seeking Alpha |
| 2025-10-28 | -2.5% | news | ChartMill | ResMed Inc (NYSE:RMD) Stands Out as a Quality Investment with Strong Financials - ChartMill |
| 2026-02-02 | -2.3% | news | Yahoo Finance | ResMed Inc. (RMD): A Bull Case Theory - Yahoo Finance |
| 2026-04-08 | -2.3% | earnings | MarketBeat | ResMed Inc. $RMD Shares Sold by Pacific Point Advisors LLC - MarketBeat |
| 2026-04-08 | -2.3% | earnings | Xã Thanh Hà | RMD Q2 2026 Earnings: ResMed Inc. beats EPS estimates, posts $2.81 per share - Pro Trader Recommendations - Xã Thanh Hà |
| 2026-04-08 | -2.3% | earnings | UBND thành phố Hải Phòng | Is ResMed (RMD) Stock defensive in downturns | RMD Q2 2026 Earnings: ResMed Inc. beats EPS estimates, posts $2.81 per share - Share Dilution - UBND thành phố Hải Phòng |
| 2026-04-08 | -2.3% | earnings | UBND thành phố Hải Phòng | RMD Q2 2026 Earnings: ResMed Inc. beats EPS estimates, posts $2.81 per share - UBND thành phố Hải Phòng |
| 2026-04-20 | -2.2% | earnings | Zacks | Why ResMed (RMD) is Poised to Beat Earnings Estimates Again |
| 2026-04-20 | -2.2% | earnings | Zacks | How to Find Strong Medical Stocks Slated for Positive Earnings Surprises |
| 2026-04-21 | -2.2% | news | Yahoo Finance Singapore | ResMed Inc. (RMD) stock price, news, quote and history - Yahoo Finance Singapore |
| 2026-04-21 | -2.2% | earnings | MarketBeat | Mirae Asset Global Investments Co. Ltd. Boosts Position in ResMed Inc. $RMD - MarketBeat |
| 2022-07-01 | +2.0% | legal | SEC EDGAR | RMD 8-K: 5.02 and (SEC Filing) |
| 2025-11-14 | -2.0% | news | MarketWatch | ResMed Inc. stock falls Friday, underperforms market - MarketWatch |
| 2025-10-30 | -1.9% | earnings | Seeking Alpha | ResMed Non-GAAP EPS of $2.55 beats by $0.05, revenue of $1.3B misses by $30M |
| 2025-10-30 | -1.9% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-10-30 | -1.9% | earnings | Yahoo Finance | ResMed Inc (RMD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - Yahoo Finance |
| 2025-10-30 | -1.9% | earnings | ChartMill | Resmed Inc (NYSE:RMD) Reports Q1 FY2026 Results: Mixed Earnings Beat Fails to Prevent Stock Decline - ChartMill |
| 2026-02-01 | -1.9% | news | Seeking Alpha | ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell |
| 2026-01-31 | -1.9% | earnings | Seeking Alpha | ResMed Inc. 2026 Q2 - Results - Earnings Call Presentation |
| 2025-10-31 | -1.8% | news | Seeking Alpha | ResMed declares $0.60 dividend |
| 2025-10-31 | -1.8% | earnings | Seeking Alpha | ResMed Inc. 2026 Q1 - Results - Earnings Call Presentation |
| 2025-10-31 | -1.8% | expansion | Seeking Alpha | ResMed outlines high single-digit growth targets for mask segment as new fabric mask launches drive innovation |
| 2025-10-31 | -1.8% | earnings | Seeking Alpha | ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript |
| 2025-10-31 | -1.8% | news | Yahoo Finance | Is It Time To Consider Buying ResMed Inc. (NYSE:RMD)? - Yahoo Finance |
| 2025-10-31 | -1.8% | earnings | Yahoo Finance | Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand - Yahoo Finance |
| 2026-03-12 | -1.8% | news | Yahoo Finance | Is ResMed Stock Underperforming the Nasdaq? - Yahoo Finance |
| 2025-12-04 | +1.8% | news | Investing.com | ResMed director Farrell sells $502k in stock - Investing.com |
| 2025-11-13 | -1.6% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector rises to 2.00% in October; MRNA stays most shorted stock |
| 2026-03-02 | +1.6% | news | Stock Titan | RMD (NYSE: RMD) broker files Rule 144 notice for 1,000 shares - Stock Titan |
| 2021-10-07 | -1.6% | legal | SEC EDGAR | RMD 8-K: 5.02 (SEC Filing) |
| 2025-12-12 | +1.5% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector rises to 2.12% in November; MRNA stays most shorted stock |
| 2025-12-16 | -1.4% | analyst | Seeking Alpha | Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 |
| 2026-04-23 | -1.4% | earnings | Zacks | ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth |
| 2026-04-23 | -1.4% | earnings | Zacks | Resmed's Q3 Earnings on Deck: What's in Store for the Stock? |
| 2026-04-23 | -1.4% | news | GlobeNewswire | Long-Term Care and Home Healthcare Global Market Analysis and Technology Research Report 2026-2030, Profiles of Leading Players - Baxter, Medtronic, Koninklijke Philips, ResMed, Sunrise Medical |
| 2026-04-23 | -1.4% | news | ChartMill | RMD Stock Price, Quote & Chart | RESMED INC (NYSE:RMD) - ChartMill |
| 2026-04-23 | -1.4% | earnings | MarketBeat | Zurcher Kantonalbank Zurich Cantonalbank Reduces Stock Position in ResMed Inc. $RMD - MarketBeat |
| 2026-04-23 | -1.4% | earnings | TradingView | Resmed's Q3 Earnings on Deck: What's in Store for the Stock? - TradingView |
| 2026-04-23 | -1.4% | earnings | MarketBeat | ResMed Inc. $RMD Shares Purchased by KLP Kapitalforvaltning AS - MarketBeat |
| 2026-04-23 | -1.4% | earnings | MarketBeat | ResMed (NYSE:RMD) Reaches New 52-Week Low - What's Next? - MarketBeat |
| 2026-01-13 | +1.3% | news | Seeking Alpha | 44th Annual J.P. Morgan Healthcare Conference |
| 2026-01-30 | -1.3% | news | Seeking Alpha | ResMed declares $0.60 dividend |
| 2026-01-30 | -1.3% | news | Seeking Alpha | ResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments |
| 2026-01-30 | -1.3% | earnings | Seeking Alpha | ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript |
| 2026-01-30 | -1.3% | earnings | ChartMill | ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion - ChartMill |
| 2026-04-09 | -1.3% | earnings | MarketBeat | Citigroup Issues Pessimistic Forecast for ResMed (NYSE:RMD) Stock Price - MarketBeat |
| 2026-04-09 | -1.3% | executive | Stock Titan | ResMed (RMD) CEO Farrell sells 4,991 shares after option exercise - Stock Titan |
| 2026-04-09 | -1.3% | earnings | MarketBeat | ResMed (NYSE:RMD) CEO Michael Farrell Sells 4,991 Shares - MarketBeat |
| 2025-10-25 | -1.3% | analyst | TIKR.com | ResMed Stock Prediction: Where Analysts See the Stock Going by 2028 - TIKR.com |
| 2026-03-13 | -1.2% | earnings | MarketBeat | Mackenzie Financial Corp Trims Stock Position in ResMed Inc. $RMD - MarketBeat |
| 2026-03-13 | -1.2% | earnings | MarketBeat | Landscape Capital Management L.L.C. Boosts Stake in ResMed Inc. $RMD - MarketBeat |
| 2026-02-16 | +1.1% | news | DirectorsTalk Interviews | ResMed Inc. (RMD) Stock Analysis: Evaluating A 17.79% Potential Upside For Investors - DirectorsTalk Interviews |
| 2026-02-15 | +1.1% | earnings | Yahoo Finance | ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings - Yahoo Finance |
| 2026-03-19 | +1.1% | news | Yahoo Finance | After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD) - Yahoo Finance |
| 2022-06-30 | +1.1% | legal | SEC EDGAR | RMD 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-08-11 | -1.1% | news | Yahoo Finance | Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Yahoo Finance |
| 2026-01-08 | +1.1% | executive | Investing.com | Farrell, ResMed CEO, sells $1.24 million in RMD stock - Investing.com |
| 2026-01-08 | +1.1% | news | TradingView | Is This the Right Time to Add Resmed Stock to Your Portfolio? - TradingView |
| 2026-01-28 | +1.0% | earnings | Seeking Alpha | ResMed Q2 2026 Earnings Preview |
| 2026-04-01 | -1.0% | earnings | Stock Titan | Resmed to post quarterly results after market close on April 30 - Stock Titan |
| 2026-04-01 | -1.0% | news | Stock Titan | Affiliate proposes three 1,000-share sales for RMD (NYSE: RMD) — broker listed - Stock Titan |
| 2026-04-01 | -1.0% | news | Stock Titan | Peter C. Farrell (RMD) sells 6,000 shares via Rule 144 notices (NYSE: RMD) - Stock Titan |
| 2026-01-02 | +1.0% | news | simplywall.st | ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 69% of the company - simplywall.st |
| 2025-10-20 | -1.0% | news | Yahoo Finance | Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance |
| 2025-08-18 | +1.0% | legal | SEC EDGAR | RMD 8-K: 5.02 and (SEC Filing) |
| 2026-02-06 | +0.9% | earnings | Yahoo Finance | RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand - Yahoo Finance |
| 2026-02-06 | +0.9% | earnings | TradingView | RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand - TradingView |
| 2026-02-06 | +0.9% | news | Investing.com | Resmed director Farrell sells $502k in stock - Investing.com |
| 2026-03-27 | +0.9% | news | Stock Titan | Vanguard (RMD) disaggregates holdings; reports zero ownership in ResMed - Stock Titan |
| 2026-01-12 | +0.9% | news | Seeking Alpha | ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-03-03 | +0.8% | executive | Stock Titan | ResMed (NYSE: RMD) CFO sells 1,000 shares in Rule 10b5-1 trade - Stock Titan |
| 2026-03-03 | +0.8% | news | Stock Titan | People say sleep matters most for health, yet quality rest is rare - Stock Titan |
| 2025-09-23 | +0.8% | news | Seeking Alpha | ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript |
| 2025-08-15 | +0.7% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock |
| 2026-03-30 | -0.7% | earnings | MarketBeat | SG Americas Securities LLC Cuts Stock Position in ResMed Inc. $RMD - MarketBeat |
| 2026-01-29 | +0.7% | earnings | Seeking Alpha | ResMed Non-GAAP EPS of $2.81 beats by $0.09, revenue of $1.4B in-line |
| 2026-01-29 | +0.7% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2026-01-29 | +0.7% | news | ChartMill | ResMed Inc (NYSE:RMD) Stands Out as a High-Quality Dividend Stock - ChartMill |
| 2026-01-29 | +0.7% | news | Yahoo Finance | Are Medical Stocks Lagging ResMed (RMD) This Year? - Yahoo Finance |
| 2026-01-29 | +0.7% | earnings | TradingView | ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations - TradingView |
| 2026-01-29 | +0.7% | news | MEXC Exchange | RMD Price Today: ResMed Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange |
| 2025-12-02 | +0.7% | executive | Investing.com | Resmed CFO Sandercock sells $244,160 in stock - Investing.com |
| 2022-06-14 | -0.7% | legal | SEC EDGAR | RMD 8-K: 1.01, 7.01 (SEC Filing) |
| 2026-04-19 | -0.7% | analyst | Insider Monkey | JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT |
| 2026-04-18 | -0.7% | earnings | MarketBeat | Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD - MarketBeat |
| 2025-10-29 | -0.6% | earnings | Seeking Alpha | ResMed Q1 2026 Earnings Preview |
| 2024-08-16 | +0.6% | legal | SEC EDGAR | RMD 8-K: 5.02 and (SEC Filing) |
| 2023-03-30 | +0.6% | legal | SEC EDGAR | RMD 8-K: 5.02 and (SEC Filing) |
| 2025-09-01 | -0.5% | news | ChartMill | ResMed Inc. (NYSE:RMD): A Top Dividend Stock for Sustainable Income and Growth - ChartMill |
| 2025-09-15 | +0.5% | legal | Seeking Alpha | Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock |
| 2026-01-27 | +0.5% | earnings | Yahoo Finance | Resmed's Q2 Earnings on Deck: What's in Store for the Stock? - Yahoo Finance |
| 2026-01-27 | +0.5% | earnings | TradingView | ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect - TradingView |
| 2025-11-24 | -0.4% | news | DirectorsTalk Interviews | ResMed Inc. (RMD) Stock Analysis: Healthcare Giant With A 17% Potential Upside - DirectorsTalk Interviews |
| 2026-04-17 | -0.4% | news | StockStory | 1 of Wall Street’s Favorite Stock Worth Investigating and 2 Facing Headwinds |
| 2026-04-17 | -0.4% | news | Zacks | Should You Continue to Hold Resmed Stock in Your Portfolio? |
| 2026-04-17 | -0.4% | earnings | MarketBeat | KBC Group NV Has $57.23 Million Position in ResMed Inc. $RMD - MarketBeat |
| 2026-04-17 | -0.4% | news | TradingView | Should You Continue to Hold Resmed Stock in Your Portfolio? - TradingView |
| 2026-04-17 | -0.4% | earnings | MarketBeat | Hendershot Investments Inc. Increases Holdings in ResMed Inc. $RMD - MarketBeat |
| 2026-04-02 | +0.4% | news | Stock Titan | ResMed (NYSE: RMD) director sells 2,000 shares under Rule 10b5-1 plan - Stock Titan |
| 2026-04-02 | +0.4% | earnings | MarketBeat | Insider Selling: ResMed (NYSE:RMD) Director Sells 2,000 Shares of Stock - MarketBeat |
| 2026-04-06 | +0.4% | earnings | MarketBeat | 4,837 Shares in ResMed Inc. $RMD Acquired by Runnymede Capital Advisors Inc. - MarketBeat |
| 2021-08-05 | -0.3% | legal | SEC EDGAR | RMD 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-05-11 | +0.2% | legal | SEC EDGAR | RMD 8-K: 5.02 and (SEC Filing) |
| 2025-12-03 | -0.2% | news | Zacks Investment Research | Should You Continue to Hold RMD Stock in Your Portfolio? - December 3, 2025 - Zacks Investment Research |
| 2025-12-03 | -0.2% | news | TradingView | Should You Continue to Hold RMD Stock in Your Portfolio? - TradingView |
| 2025-09-14 | -0.1% | news | Yahoo Finance | How Is ResMed's Stock Performance Compared to Other Healthcare Stocks? - Yahoo Finance |
| 2026-03-16 | -0.1% | analyst | Seeking Alpha | ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating |
| 2026-03-16 | -0.1% | news | Seeking Alpha | Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions |
| 2026-03-16 | -0.1% | analyst | Seeking Alpha | ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating (NYSE:RMD) - Seeking Alpha |
| 2026-04-04 | -0.1% | earnings | MarketBeat | Wealth Enhancement Advisory Services LLC Has $1.66 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat |
| 2026-04-04 | -0.1% | earnings | MarketBeat | Aberdeen Group plc Sells 37,737 Shares of ResMed Inc. $RMD - MarketBeat |
| 2026-04-04 | -0.1% | earnings | MarketBeat | Element Squared LLC Buys Shares of 6,067 ResMed Inc. $RMD - MarketBeat |
| 2026-04-04 | -0.1% | earnings | MarketBeat | ResMed Inc. (NYSE:RMD) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat |
| 2026-04-03 | -0.1% | executive | Stock Titan | ResMed (RMD) CFO Sandercock sells 1,000 shares in open market trade - Stock Titan |
| 2026-04-03 | -0.1% | earnings | MarketBeat | Spire Wealth Management Cuts Stock Holdings in ResMed Inc. $RMD - MarketBeat |
| 2026-04-03 | -0.1% | earnings | MarketBeat | J. Safra Sarasin Holding AG Sells 10,794 Shares of ResMed Inc. $RMD - MarketBeat |
| 2021-08-27 | +0.1% | legal | SEC EDGAR | RMD 8-K: 5.02 (SEC Filing) |
| 2026-03-17 | -0.0% | news | Yahoo Finance | After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD) - Yahoo Finance |
| 2026-03-17 | -0.0% | analyst | Yahoo Finance | ResMed (RMD) Upgraded to Buy: Here's What You Should Know - Yahoo Finance |
| 2025-12-30 | +0.0% | news | Yahoo Finance | Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance |
| 2025-12-30 | +0.0% | news | TradingView | BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now? - TradingView |
| 2025-12-30 | +0.0% | news | The Globe and Mail | BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now? - The Globe and Mail |
| 2026-04-07 | -0.0% | news | Stock Titan | Affiliate plans sale of 4,991 RMD shares via Fidelity (NYSE: RMD) - Stock Titan |
| 2026-04-07 | -0.0% | news | The Globe and Mail | ResMed Director Peter Farrell Plans Further Insider Share Sale Under Rule 144 - The Globe and Mail |
| 2025-12-09 | +0.0% | legal | Yahoo Finance | RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort - Yahoo Finance |
| 2026-04-25 | — | news | Simply Wall St. | Is It Time To Reassess ResMed (RMD) After Recent Share Price Weakness |
| 2026-04-24 | — | earnings | MarketBeat | Universal Beteiligungs und Servicegesellschaft mbH Buys 6,095 Shares of ResMed Inc. $RMD - MarketBeat |